A61P 15/16
Masculine contraceptives
A61P15/16 (Masculine contraceptives) appears on 539 US grants and 772 published applications in this corpus.
Search patents in A61P- Granted patents
- 539
- Published applications
- 772
- Assignees
- 317
- Inventors
- 1,358
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 11 | 0 |
| 1999 | 8 | 0 |
| 2000 | 12 | 0 |
| 2001 | 21 | 4 |
| 2002 | 17 | 25 |
| 2003 | 23 | 56 |
| 2004 | 20 | 59 |
| 2005 | 15 | 54 |
| 2006 | 20 | 55 |
| 2007 | 18 | 41 |
| 2008 | 29 | 56 |
| 2009 | 20 | 54 |
| 2010 | 46 | 41 |
| 2011 | 31 | 46 |
| 2012 | 35 | 25 |
| 2013 | 27 | 21 |
| 2014 | 26 | 31 |
| 2015 | 17 | 26 |
| 2016 | 21 | 35 |
| 2017 | 19 | 22 |
| 2018 | 23 | 21 |
| 2019 | 14 | 19 |
| 2020 | 11 | 17 |
| 2021 | 10 | 13 |
| 2022 | 9 | 12 |
| 2023 | 4 | 10 |
| 2024 | 4 | 10 |
| 2025 | 4 | 11 |
| 2026 | 4 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Contraceptive vaccine based on the sperm-associated protein catsper2 Jun 2026US 12,642,843 B2Rensselaer Polytechnic Institute
- Methods and compositions of inhibiting DCN1-UBC12 interaction21 Apr 2026US 12,605,373 B2Memorial Sloan Kettering Cancer Center
- Occlusive implant compositions31 Mar 2026US 12,589,182 B2University of Virginia Patent Foundation
- Nanoparticles for targeted non-surgical spaying and neutering13 Jan 2026US 12,521,354 B2University of Georgia Research Foundation, Inc.
- Progestin/testosterone transdermal gel23 Dec 2025US 12,502,395 B2The Population Council, Inc.
- Bromodomain Inhibitors27 Aug 2026US 2026/0250279 A1AbbVie Inc.
- Contraceptive compounds and dosing for the same9 Jul 2026US 2026/0191825 A1YourChoice Therapeutics, Inc.
- Enhanced sensation condom4 Jun 2026US 2026/0151257 A1Nuceptive Labs, Inc.
- Progestin/Testosterone Transdermal Gel12 Mar 2026US 2026/0069607 A1The Population Council, Inc.
- Therapeutic compounds and methods22 Jan 2026US 2026/0022124 A1
Most cited
By later US patents
- Water-soluble non-antigenic polymer linkable to biologically active material304US 6,113,906 AEnzon, Inc. · 2000
- Dermal penetration enhancers and drug delivery systems involving same297US 6,299,900 B1Monash University · 2001
- Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines290US 6,218,371 B1University of Iowa Research Foundation · 2001
- Pyrazolopyrimidines as therapeutic agents276US 6,660,744 B1Abbott GmbH & Co. KG · 2003
- Non-antigenic branched polymer conjugates264US 5,919,455 AEnzon, Inc. · 1999